LRMR
Price
$3.72
Change
+$0.14 (+3.91%)
Updated
Aug 11, 04:44 PM (EDT)
Capitalization
306.41M
Earnings call today
QNCX
Price
$1.58
Change
-$0.07 (-4.24%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
88.48M
One day until earnings call
Interact to see
Advertisement

LRMR vs QNCX

Header iconLRMR vs QNCX Comparison
Open Charts LRMR vs QNCXBanner chart's image
Larimar Therapeutics
Price$3.72
Change+$0.14 (+3.91%)
Volume$1.2K
Capitalization306.41M
Quince Therapeutics
Price$1.58
Change-$0.07 (-4.24%)
Volume$549
Capitalization88.48M
LRMR vs QNCX Comparison Chart in %
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. QNCX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (LRMR: $3.58 vs. QNCX: $1.65)
Brand notoriety: LRMR and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 91% vs. QNCX: 69%
Market capitalization -- LRMR: $306.41M vs. QNCX: $88.48M
LRMR [@Biotechnology] is valued at $306.41M. QNCX’s [@Biotechnology] market capitalization is $88.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, both LRMR and QNCX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 3 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 3 bullish, 5 bearish.
  • QNCX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, QNCX is a better buy in the short-term than LRMR.

Price Growth

LRMR (@Biotechnology) experienced а +4.07% price change this week, while QNCX (@Biotechnology) price change was -1.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

LRMR is expected to report earnings on Aug 11, 2025.

QNCX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($306M) has a higher market cap than QNCX($88.5M). LRMR YTD gains are higher at: -7.494 vs. QNCX (-11.765). QNCX has higher annual earnings (EBITDA): -40.25M vs. LRMR (-105.02M). LRMR has more cash in the bank: 158M vs. QNCX (31.6M). LRMR has less debt than QNCX: LRMR (4.87M) vs QNCX (15.8M). LRMR (0) and QNCX (0) have equivalent revenues.
LRMRQNCXLRMR / QNCX
Capitalization306M88.5M346%
EBITDA-105.02M-40.25M261%
Gain YTD-7.494-11.76564%
P/E RatioN/AN/A-
Revenue00-
Total Cash158M31.6M500%
Total Debt4.87M15.8M31%
FUNDAMENTALS RATINGS
LRMR vs QNCX: Fundamental Ratings
LRMR
QNCX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4538
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (27) in the null industry is in the same range as QNCX (46) in the Biotechnology industry. This means that LRMR’s stock grew similarly to QNCX’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as QNCX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to QNCX’s over the last 12 months.

QNCX's SMR Rating (99) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that QNCX’s stock grew similarly to LRMR’s over the last 12 months.

QNCX's Price Growth Rating (38) in the Biotechnology industry is in the same range as LRMR (45) in the null industry. This means that QNCX’s stock grew similarly to LRMR’s over the last 12 months.

QNCX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that QNCX’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRQNCX
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 22 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABOIF0.63N/A
N/A
Aboitiz Equity Ventures, Inc.
HPTO0.05N/A
N/A
hopTo Inc.
MENEF0.12N/A
N/A
Mene Inc.
MTGRY2.30N/A
N/A
Mount Gibson Iron Ltd.
NBGRY15.25-0.09
-0.55%
NATIONAL BK GREECE S A

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SYRE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-2.19%
SYRE - LRMR
50%
Loosely correlated
N/A
ERAS - LRMR
49%
Loosely correlated
-4.11%
ACLX - LRMR
49%
Loosely correlated
-0.91%
EYPT - LRMR
49%
Loosely correlated
N/A
OCUL - LRMR
48%
Loosely correlated
-0.73%
More

QNCX and

Correlation & Price change

A.I.dvisor tells us that QNCX and MNPR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNCX and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-1.20%
MNPR - QNCX
31%
Poorly correlated
-9.61%
KOD - QNCX
28%
Poorly correlated
-3.66%
LRMR - QNCX
25%
Poorly correlated
-2.19%
SRZN - QNCX
24%
Poorly correlated
+5.87%
LQDA - QNCX
24%
Poorly correlated
N/A
More